CDKN1A and Alzheimer disease: We characterized novel gene associations with AD (particularly CDKN1A and CLOCK in mitochondrial contexts), delineated AD‐relevant ceRNA networks, and demonstrated the utility of mitochondria‐specific polygenic risk scores.